Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference48 articles.
1. Evaluation of the BNT162b2 covid-19 vaccine in children 5 to 11 years of age;Walter;N Engl J Med,2022
2. Safety, immunogenicity, and efficacy of the BNT162b2 covid-19 vaccine in adolescents;Frenck;N Engl J Med,2021
3. Evaluation of mRNA-1273 covid-19 vaccine in children 6 to 11 years of age;Creech;N Engl J Med,2022
4. Zambrano LD, Newhams MM. OSM i wsp. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA vaccination against multisystem inflammatory syndrome in children among persons aged 12–18 YearsEffectiveness of BNT162b2 (Pfizer-BioNTech) mRNA vaccination against multisystem inflammatory syndrome in chil. 2021;71(2):52–8. Available from: https://www.cdc.gov/mmwr/volumes/71/wr/mm7102e1.htm.
5. Multisystem inflammatory syndrome in children by COVID-19 vaccination status of adolescents in France;Levy;JAMA - J Am Med Assoc,2022